Global Citrus Bioflavonoids Market By Type (Coventional, Organic), By Product Type (Hesperidin, Eriocitrin And Others), By Source (Orange, Tangarines And Others), Application (Pharmaceuticals And Others) And By Region – Global Forecast To 2031

MarketResearch.biz announces publication of its most recently generated research report titled, “Global Citrus Bioflavonoids Market by Type (Coventional, Organic), By Product Type (Hesperidin, Eriocitrin, Apigenin, Diosmin, Naringin, Narirutin), By Source (Orange, Tangarines, Mandarins, Limes & Lemons & Grapefruit), Application (Pharmaceuticals, Dietary Supplements, Food & Beverages, Animal Feed & Cosmetics), and by Region – Global Forecast to 2031”, which offers a holistic view of the global Citrus Bioflavonoids Market through systematic segmentation that covers every aspect of the target market. The Global Citrus Bioflavonoids Market is projected to be US$ 817.5 Mn in 2021 to reach US$ 1,739.9 Mn by 2031 at a CAGR of 7.5%.

Request Covid - 19 Impact

Bioflavonoids or flavonoids are a family of polyphenolic compounds found in the plant kingdom. More than 4000 flavonoids known-to-date are found in the human diet as natural components of vegetables, fruits, and beverages such as wine and tea. Flavonoids are comprised of two aromatic rings (A and B) that are connected by three carbon atoms, which combine with an oxygen atom and two carbon atoms from the aromatic A-ring to form a third oxygenated heterocycle ring (C-ring). Albert Szent-Gyorgi, a Nobel Prize winner and pioneer in vitamin C science, first discovered bioflavonoids in 1936 and named the group of compounds "vitamin P." Since then, vast numbers of flavonoids have been detected and labeled based on their chemical structure. Bioflavonoids are majorly extracted from citrus fruits such as oranges, tangerines, mandarins, lemons, and grapefruit.

Global Citrus Bioflavonoids Market Revenue (US$ Mn), 2021–2031

The increasing prevalence and incidence of diseases such as diabetes, cardiovascular disease, blood pressure, and hemorrhoid all over the world are anticipated to further augment revenue growth prospects for the global citrus bioflavonoids market. Citrus bioflavonoids are used to prevent these aforementioned diseases as it possesses antibacterial, antiviral, antioxidant, blood pressure reduction, anti-inflammatory properties. Also, the increasing awareness concerning several benefits associated with the use of citrus bioflavonoids among end-use industries and end-users are expected to further boost the revenue growth of this market over the forecast period. In the food industry, it can be used both as a flavoring agent and a preservative. Moreover, owing to its antibacterial properties the use of citrus bioflavonoids has increased in oral care products as well. The consistent increases in healthcare expenditures of both developed and emerging nations have resulted in increased consumer spending on several dietary supplements. In addition, the number of fitness enthusiasts and health-conscious individuals is also increasing. These factors are anticipated to augment revenue growth prospects for this target market.

Not all uses for bioflavonoids have been approved by several government authorities such as the Food and Drug Administration (FDA). In addition, citrus bioflavonoids can only be applied to the skin and taken orally in small amounts for a short duration. There hasn't been enough research completed to establish whether it's safe for use over longer durations of time. It's also unclear whether it's safe for pregnant or breastfeeding women. These are factors that may potentially restrain the revenue growth of this market. Additionally, the value and supply chains of the pharmaceutical industry are complex and distributed across all regions. Lockdowns in various countries have restricted the movement of non-essential goods and resources both nationally and internationally, which has, in turn, put the brakes on the supply of raw materials that are required to produce citrus bioflavonoids.

In recent years, the sale of nutraceuticals through e-commerce platforms has significantly increased. These platforms allow manufacturers to directly connect with potential customers that may be based in varying countries or regions, resulting in new opportunities for increased sales. Major industry players are building their respective e-commerce platforms/websites to reach a greater number of customers. Moreover, citrus bioflavonoids help to increase the overall immunity levels of the body. After the COVID-19 outbreak, individuals are trying to increase their given immunity levels through the use of several supplementary products. This trend is expected to garner significant traction in the coming years, thus facilitating stable revenue growth for this global sector.

The global citrus bioflavonoids market is segmented accordingly – by type, product type, source, application and region. With respect to the type aspect of this market's segmentation, the conventional sub-segment is anticipated to register the highest revenue share the forecast period. On the basis of the product type segment, the Hesperidin sub-segment is slated to account for the highest number of revenue shares. Among source segments, the orange sub-segment is anticipated to capture highest market share. On the basis of the application segment, the food & beverages sub-segment is anticipated register highest revenue growth. With respect to segmentation by region, the markets in North America are projected to continue to account for the majority revenue share of the global citrus bioflavonoids market.

Global Citrus Bioflavonoids Market Attractiveness Analysis by Type, 2014–2030

By region, the market is segmented into North America, Europe, APAC, South America and Middle East Africa. Based on the region, North America market is estimated to account for major revenue share and is projected to dominate the global Citrus Bioflavonoids Market in the next coming years. This is owing to high production of blueberries in US and Canada and rapidly growing food and beverage industries in countries in the region. The Asia Pacific market is projected to grow at a rapid rate in the target market over the forecast period, owing to increasing awareness among health conscious individuals with preference for balanced diet and preference for convenient and healthy snack options.

The research report on the global Citrus Bioflavonoids Market includes profiles of some of the major companies such as Merck KGaA, Cayman Chemical Company Inc., Natural Factors Inc., J & K Scientific Ltd., Santa Cruz Biotechnology, Inc., Hunan Sunfull Bio-tech Co., Ltd, Bordas SA, MORRE-TEC Industries., Yaan Times Biotech Co. Ltd, Hunan Yuantong Pharmaceutical Co., Ltd, Nans Products.

Global Citrus Bioflavonoids Market Segmentation Based on Type, Product Type, Source, Application, and Region

Based on Type

• Conventional
• Organic

Based on Product Type

• Hesperidin
• Eriocitrin
• Apigenin
• Diosmin
• Naringin
• Narirutin

Based on Source

• Orange
• Tangarines
• Mandarins
• Limes & Lemons
• Grapefruit

Based on Application

• Pharmaceuticals
• Dietary Supplements
• Food & Beverages
• Animal Feed
• Cosmetics

Based on Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa